Published in Endocrinology on February 24, 2010
Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. Glia (2011) 1.11
Inflammation as death or life signal in diabetic fracture healing. Inflamm Res (2010) 0.93
STAT3 modulates cigarette smoke-induced inflammation and protease expression. Front Physiol (2013) 0.90
PhenomeExpress: a refined network analysis of expression datasets by inclusion of known disease phenotypes. Sci Rep (2015) 0.89
Thrombospondin-1 inhibits osteogenic differentiation of human mesenchymal stem cells through latent TGF-β activation. Biochem Biophys Res Commun (2012) 0.89
Extensive mannose phosphorylation on leukemia inhibitory factor (LIF) controls its extracellular levels by multiple mechanisms. J Biol Chem (2011) 0.84
Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology. Orphanet J Rare Dis (2014) 0.83
Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma. Am J Pathol (2016) 0.75
Role of suppressors of cytokine signaling 3 in bone inflammatory responses. Front Immunol (2014) 0.75
Rhizoma Dioscoreae extract protects against alveolar bone loss in ovariectomized rats via microRNAs regulation. Nutrients (2015) 0.75
Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 25.94
Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature (2003) 20.48
Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol (2005) 11.18
Non-Smad TGF-beta signals. J Cell Sci (2005) 6.06
Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol (1998) 3.70
TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell (2009) 3.38
Transforming growth factor-beta1 to the bone. Endocr Rev (2005) 3.13
Cancer and bone. Endocr Rev (1998) 1.77
TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. Exp Cell Res (2008) 1.69
Conditional gene ablation of Stat3 reveals differential signaling requirements for survival of motoneurons during development and after nerve injury in the adult. J Cell Biol (2002) 1.69
Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. J Clin Invest (1997) 1.65
Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone. PLoS One (2008) 1.60
TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses. Oncogene (2002) 1.53
Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFkappaB pathways to maintain osteoclast survival. J Cell Biochem (2003) 1.53
Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature (2008) 1.52
The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Mol Cell Biol (2003) 1.44
The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J Bone Miner Res (2001) 1.44
A delicate balance: TGF-beta and the tumor microenvironment. J Cell Biochem (2007) 1.38
Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition. Nat Cell Biol (2005) 1.37
Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. J Cell Physiol (2004) 1.28
Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr Rev (2000) 1.28
Osteoclast synthesis and secretion and activation of latent transforming growth factor beta. J Bone Miner Res (1994) 1.22
Loss of SOCS3 gene expression converts STAT3 function from anti-apoptotic to pro-apoptotic. J Biol Chem (2006) 1.19
Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma. Cancer Res (2001) 1.18
PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells. Leukemia (2004) 1.11
Survival and morphology of auditory neurons in dissociated cultures of newborn mouse spiral ganglion. Neuroscience (2006) 1.03
Involvement of leukemia inhibitory factor and nerve growth factor in the development of dorsal root ganglion neurons. Development (1993) 0.99
Osteolysis and cancer. J Clin Invest (2001) 0.99
Transforming growth factor beta1, bone connection. Med Sci Monit (2006) 0.98
Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and up-regulation of 14-3-3. Proteomics (2008) 0.98
Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation. Cancer Sci (2008) 0.95
The Jak/Stat pathway: a novel way to regulate PI3K activity. Cell Cycle (2005) 0.93
Loss of leukemia inhibitory factor receptor beta or cardiotrophin-1 causes similar deficits in preganglionic sympathetic neurons and adrenal medulla. J Neurosci (2006) 0.91
Leukemia inhibitory factor prevents the death of axotomised sensory neurons in the dorsal root ganglia of the neonatal rat. J Neurosci Res (1994) 0.91
Transforming growth factor-beta enables NFATc1 expression during osteoclastogenesis. Biochem Biophys Res Commun (2007) 0.91
Leukemia inhibitory factor promotes olfactory sensory neuronal survival via phosphoinositide 3-kinase pathway activation and Bcl-2. J Neurosci Res (2009) 0.89
Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-alpha. J Immunol (1993) 0.87
Requirement for phosphatidylinositol-3'-kinase in cytokine-mediated germ cell survival during fetal oogenesis in the mouse. Endocrinology (1999) 0.87
Role of Bid-induced mitochondrial outer membrane permeabilization in granzyme B-induced apoptosis. Immunol Cell Biol (2006) 0.87
Production of leukemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor alpha. Arthritis Rheum (1993) 0.85
Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes. J Mol Cell Cardiol (2006) 0.84
Leukaemia inhibitory factor (LIF) production in a mouse model of spinal trauma. Neurosci Lett (1998) 0.84
Leukaemia inhibitory factor rescues motoneurones from axotomy-induced cell death. Neuroreport (1994) 0.82
LIF mRNA expression is transcriptionally regulated in murine bone marrow stromal cells. Leukemia (1993) 0.82
Osteoclast function in Paget's disease and multiple myeloma. Bone (1995) 0.81
Cytokine-cytokine synergy and protein kinase C in the regulation of lung fibroblast leukemia inhibitory factor. Am J Physiol (1994) 0.80
Interleukin-1 involvement in the induction of leukemia inhibitory factor mRNA expression following axotomy of sympathetic ganglia. J Neuroimmunol (1996) 0.79
Leukaemia inhibitory factor expression in cultured rat anterior pituitary is regulated by glucocorticoids. J Neuroendocrinol (1995) 0.78
Transcriptional regulation of the human 'leukemia inhibitory factor' gene: modulation by glucocorticoids and estradiol. Mol Cell Endocrinol (1997) 0.78
Identification of leukemia inhibitory factor as a potent mast cell growth-enhancing factor produced by mouse keratinocyte cell line, KCMH-1. Arch Dermatol Res (2001) 0.77
Leukaemia inhibitory factor expression is inhibited by glucocorticoids through post-transcriptional mechanisms. Cytokine (1999) 0.77
Human breast cancer cells induced angiogenesis, recruitment, and activation of osteoclasts in osteolytic metastasis. J Cancer Res Clin Oncol (2000) 0.77
Building bone to reverse osteoporosis and repair fractures. J Clin Invest (2008) 2.40
Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A (2008) 2.39
Update on Wnt signaling in bone cell biology and bone disease. Gene (2011) 2.03
TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. Exp Cell Res (2008) 1.69
TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. Mol Cell Biol (2005) 1.56
Regulation of circulating sclerostin levels by sex steroids in women and in men. J Bone Miner Res (2011) 1.53
Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFkappaB pathways to maintain osteoclast survival. J Cell Biochem (2003) 1.53
Estrogen and the skeleton. Trends Endocrinol Metab (2012) 1.46
Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. J Cell Physiol (2004) 1.28
Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins. Breast Cancer Res Treat (2003) 1.19
Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women. Bone (2011) 1.19
Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility. Breast Cancer Res Treat (2007) 1.15
The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas. Breast Cancer Res Treat (2004) 1.14
Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer. Int J Gynecol Pathol (2003) 1.09
CEACAM1 enhances invasion and migration of melanocytic and melanoma cells. Am J Pathol (2004) 1.08
Effects of chronic estrogen treatment on modulating age-related bone loss in female mice. J Bone Miner Res (2010) 1.04
FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas. Breast Cancer Res Treat (2003) 1.03
Histone deacetylase 3 is required for maintenance of bone mass during aging. Bone (2012) 1.01
Pathway crosstalk between Ras/Raf and PI3K in promotion of M-CSF-induced MEK/ERK-mediated osteoclast survival. J Cell Biochem (2008) 1.01
Estrogen receptor beta isoform-specific induction of transforming growth factor beta-inducible early gene-1 in human osteoblast cells: an essential role for the activation function 1 domain. Mol Endocrinol (2008) 1.00
Inhibition of casein kinase I delta alters mitotic spindle formation and induces apoptosis in trophoblast cells. Oncogene (2005) 0.99
Wnt10b activates the Wnt, notch, and NFκB pathways in U2OS osteosarcoma cells. J Cell Biochem (2011) 0.96
Regulation of bone turnover by sex steroids in men. J Bone Miner Res (2008) 0.95
TGF-β inducible early gene 1 regulates osteoclast differentiation and survival by mediating the NFATc1, AKT, and MEK/ERK signaling pathways. PLoS One (2011) 0.95
Osteoclast culture and resorption assays. Methods Mol Biol (2008) 0.94
Breast cancer bone metastasis and current small therapeutics. Cancer Metastasis Rev (2006) 0.94
N-myc oncogene overexpression down-regulates leukemia inhibitory factor in neuroblastoma. Eur J Biochem (2002) 0.92
2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo. Cancer Res (2007) 0.92
Sphingosine 1-phosphate (S1P) receptors 1 and 2 coordinately induce mesenchymal cell migration through S1P activation of complementary kinase pathways. J Biol Chem (2013) 0.91
Expression of the metastasis suppressor KAI1 in decidual cells at the human maternal-fetal interface: Regulation and functional implications. Am J Pathol (2007) 0.91
Native, not nitrated, cytochrome c and mitochondria-derived hydrogen peroxide drive osteoclast apoptosis. Am J Physiol Cell Physiol (2004) 0.91
Deletion of membrane-bound steel factor results in osteopenia in mice. J Bone Miner Res (2004) 0.90
TGF-β mediates suppression of adipogenesis by estradiol through connective tissue growth factor induction. Endocrinology (2011) 0.90
TGF-β induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts. Endocrinology (2013) 0.89
Expansion of human trophoblastic spheroids is promoted by decidualized endometrial stromal cells and enhanced by heparin-binding epidermal growth factor-like growth factor and interleukin-1 β. Mol Hum Reprod (2011) 0.89
IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro. Exp Cell Res (2004) 0.88
TIEG1/KLF10 modulates Runx2 expression and activity in osteoblasts. PLoS One (2011) 0.88
Osteopontin (OPN) expression in thyroid carcinoma. Anticancer Res (2010) 0.88
Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates. Reprod Biol Endocrinol (2003) 0.87
Loss of ERE binding activity by estrogen receptor-alpha alters basal and estrogen-stimulated bone-related gene expression by osteoblastic cells. J Cell Biochem (2008) 0.87
Characterization of a novel telomerase-immortalized human endometrial stromal cell line, St-T1b. Reprod Biol Endocrinol (2009) 0.86
Human endometrial stromal cell-trophoblast interactions: mutual stimulation of chemotactic migration and promigratory roles of cell surface molecules CD82 and CEACAM1. Biol Reprod (2013) 0.85
Osteopontin is colocalized with the adhesion molecule CEACAM1 in the extravillous trophoblast of the human placenta and enhances invasion of CEACAM1-expressing placental cells. J Clin Endocrinol Metab (2005) 0.84
Control of human endometrial stromal cell motility by PDGF-BB, HB-EGF and trophoblast-secreted factors. PLoS One (2013) 0.84
The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro. J Orthop Res (2002) 0.83
DC-SIGN and SRCL bind glycans of carcinoembryonic antigen (CEA) and CEA-related cell adhesion molecule 1 (CEACAM1): recombinant human glycan-binding receptors as analytical tools. Eur J Cell Biol (2010) 0.82
Expression pattern of the activating protein-1 family of transcription factors in gestational trophoblastic lesions. Int J Gynecol Pathol (2005) 0.82
Developments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions. Curr Osteoporos Rep (2014) 0.79
Correlations between reduced expression of the metastasis suppressor gene KAI-1 and accumulation of p53 in uterine carcinomas and sarcomas. Virchows Arch (2008) 0.79
Ulex europeus agglutinin-I binding as a potential prognostic marker in ovarian cancer. Anticancer Res (2007) 0.79
Temporal expression patterns of BMP receptors and collagen II (B) during periosteal chondrogenesis. J Orthop Res (2002) 0.78
Osteopontin stimulates invasion of NCI-h295 cells but is not associated with survival in adrenocortical carcinoma. J Pathol (2009) 0.77
Expression pattern of the CCAAT/enhancer-binding protein C/EBP-beta in gestational trophoblastic disease. Int J Gynecol Pathol (2004) 0.76
CEACAM1 expression in pancreatic endocrine tumors. Appl Immunohistochem Mol Morphol (2009) 0.76
Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1. Int J Gynecol Pathol (2006) 0.75
Corrigendum: Targeting cellular senescence prevents age-related bone loss in mice. Nat Med (2017) 0.75
Expression of the high-mobility group protein HMGI(Y) in gestational trophoblastic diseases. Int J Gynecol Pathol (2006) 0.75